Attached files
file | filename |
---|---|
10-Q - 10-Q - TREACE MEDICAL CONCEPTS, INC. | d513422d10q.htm |
EX-32.1 - EX-32.1 - TREACE MEDICAL CONCEPTS, INC. | d513422dex321.htm |
EX-31.2 - EX-31.2 - TREACE MEDICAL CONCEPTS, INC. | d513422dex312.htm |
EX-31.1 - EX-31.1 - TREACE MEDICAL CONCEPTS, INC. | d513422dex311.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Treace Medical Concepts, Inc. (the Company) on Form 10-Q for the period ending March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the Report), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date: May 25, 2021 |
By: |
/s/ Mark L. Hair | ||
| ||||
Mark L. Hair | ||||
Chief Financial Officer (Principal Financial and Accounting Officer) |